Targeted rescue of cancer-associated IDH1 mutant activity using an engineered synthetic antibody
Abstract We have utilized a high-diversity phage display library to engineer antibody fragments (Fabs) that can modulate the activity of the enzyme isocitrate dehydrogenase 1 (IDH1). We show that a conformation-specific Fab can reactivate an IDH1 mutant associated with brain tumors. The results show...
Guardado en:
Autores principales: | Shahir S. Rizk, Somnath Mukherjee, Akiko Koide, Shohei Koide, Anthony A. Kossiakoff |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/065572b166404feeb3517918ff5de3c8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
T cell receptor-like recognition of tumor in vivo by synthetic antibody fragment.
por: Keith R Miller, et al.
Publicado: (2012) -
Selective and noncovalent targeting of RAS mutants for inhibition and degradation
por: Kai Wen Teng, et al.
Publicado: (2021) -
ATRX regulates glial identity and the tumor microenvironment in IDH-mutant glioma
por: Husam Babikir, et al.
Publicado: (2021) -
Synthetic antibodies against BRIL as universal fiducial marks for single−particle cryoEM structure determination of membrane proteins
por: Somnath Mukherjee, et al.
Publicado: (2020) -
Induction of synthetic lethality in IDH1-mutated gliomas through inhibition of Bcl-xL
por: Georg Karpel-Massler, et al.
Publicado: (2017)